Recognized by the medical community and society for promoting access to health and quality of life at an affordable price, quality and innovative treatments, we position ourselves prominently in the main pharmaceutical segments: prescription and non-prescription, generics, hospitals and oncology, with reference in CNS (Central Nervous System), anti-infective and hormonal drugs.
Prescription Drugs
Company's main business unit, Eurofarma ranks today prominent position, being the 2nd most prescribed laboratory by the medical community.
Hospital
Unit responsible for marketing medicines and parenteral solutions of large volume, with a broad portfolio of high-tech and high quality standard products.
Bids
The unit is aimed at meeting the public health institutions, working with the entire line of Eurofarma products.
Outsourcing Services
The Unit, which started the activities of the Eurofarma Group in 1972, produces for national and international laboratories.
Nonprescription Drugs
The Unit brings together the non-prescription medicines, cosmetics and food that the company offers to the market and that can be acquired without the formalization of the medical prescription.
Export
This Unit is responsible for international sales, including exports to Eurofarma subsidiaries outside Brazil
Generic Drugs
The Eurofarma Generics division continuously works to beat one of the biggest challenges of the pharmaceutical industry: increasing population's access to quality medicines at lower prices.
Oncology
The oncological portfolio is broad and diversified. In 2015, the Fiprima® (filgrastim) was recorded, being the first biosimilar medicine in Latin America.